Verification Technologies, Inc.

Other

Companion Diagnostics Inc.

Sun Chemical Corporation

Sony Dadc US Inc

Richard H Selinfreund

Rakesh Vig

Richard P Gill

Jeffrey M Drew

Donald Roland Goyette

Peter D Miller

Scott Gerger

Anthony Saglimbeni

Ewell Cook

Junzhong Li

Fred M Berry

J Christopher Philips

Henry F McInerney

Junzhing Li

Sarka Aubrecht

Fredrich Behringer

Tony New

Paul Breslin

Mike Cunningham

Chris Phillips

Fred J Behringer

The present invention is directed to sweetened consumer goods that closely match the sweetness, caloric and satiety sensations of the sucrose-containing or high fructose corn syrup-containing consumer goods which are currently available to consumers. Reduced sugar versions of consumer goods may also be generated. The sweetened consumer goods of the invention assist to ameliorate various disease conditions such as fatty liver disease and metabolic disease associated with fructose contained in presently available consumer goods.

Sweetened consumer goods comprising exogenous flavor sources and color

Methods for determining the efficiency of a therapeutic. In at least one embodiment of a method of determining the efficacy of a therapeutic compound, the method comprises the steps of treating a subject having a disease state with an effective amount of therapeutic compound, harvesting at least one cell from the subject following a treatment with the therapeutic compound, bringing the at least one cell into contact with a stabilizing compound capable of completely or substantially preventing the degradation or inactivation of a diagnostic marker for the disease state, analyzing the at least one stabilized cell for the at least one diagnostic marker, creating a marker profile from at least one result determined from analyzing the at least one stabilized cell, and comparing the marker profile with at least one previous marker profile to determine efficacy of the therapeutic compound on the disease state.

Methods for determining the efficiency of a therapeutic

A method and apparatus for remotely controlling access to the components of an optically interconnected information processing infrastructure is presented. Access to the infrastructure is controlled independently of the infrastructure operating system.

Remote circuit locking switch system

Systems and methods of screening biomarkers in bodily fluids. According to at least one embodiment of the system for analyzing stabilizing agents of the present disclosure, the system comprises a detection platform comprising a plurality of detection sites each capable of receiving a diagnostic marker, a stabilization agent, and a detection agent. The system, in at least one embodiment, further comprises a detection device capable of determining a binding characteristic between the detection agent and the diagnostic marker in the detection sites. Further, the system may also be able to compare the binding characteristic among a plurality of detection markers to order the level of effect of the stabilizing agents assayed on the binding characteristic between the detection agent and the diagnostic agent.

Systems and methods of screening biomarkers in bodily fluids

System and methods for the detection of biomarkers. In at least one embodiment of a system for the detection of a diagnostic marker in a body fluid of the present disclosure, the system comprises a diagnostic device comprising a plurality of test wells, wherein each test well is capable of containing at least one detection agent, a detection device capable of interacting with the diagnostic device, wherein the detection device is capable of detecting an interaction between the at least one detection agent and a diagnostic marker in at least one of the plurality of test wells, and a stabilization agent contained within at least one of the plurality of test wells, the stabilization agent capable of completely or substantially preventing the degradation or inactivation of the detection agent or the diagnostic marker.

Systems and methods for the detection of biomarkers

Systems and methods of biomarker analysis. In at least one embodiment of a system for determining the therapeutic potential of a therapeutic compound the present disclosure, the system comprises a detection platform, a computer database capable of receiving a plurality of binding characteristics, a processor operably coupled to the computer database and the detection platform. In at least one embodiment, the processor has and executes a software program operational to determine a binding characteristic of the detection agent and a stabilized diagnostic agent in each of the plurality of detection sites, compare the binding characteristic among each of the plurality of detection sites, wherein the comparison of binding characteristics is capable of determining the stabilizing agent with the greatest effect on the binding characteristic between the detection agent and the diagnostic agent, generate a binding record using the compared binding characteristics, and deliver the binding record to a recipient.

Systems and methods for biomarker analysis

Systems and methods for the detection of biomarkers. In at least one embodiment of a microarray system of the present disclosure, the microarray system comprises a microarray product comprising at least 100 diagnostic markers/cm, a microarray identifier, and a stabilizing agent, a control microarray product comprising a first specific binding pair member that binds to a first detectable label, and a processor for providing information regarding the identification and concentration of markers on the microarray based on the identity of the array provided by the microarray identifier.

At least one embodiment of a stabilizing system includes a stabilizing agent present in an amount or concentration sufficient to completely or substantially prevent or reduce degradation or inactivation of a glycosylated hemoglobin (HbA1c) in a body fluid and a detection agent capable of detecting the HbA1c.

Systems and methods for hemoglobin analysis

A system for selectively enabling or disabling an optical device. In an illustrative embodiment, the system implements an optical-device theft-prevention system. The theft-prevention system includes a material that is selectively positioned on, in, or relative to the optical device so that the transparency of the material affects a desired operation of the optical device. An energy beam is selectively employed to enable or disable the optical device by affecting the transparency of the material. In a specific embodiment, the fist material includes a dye, such as an energy-sensitive dye. The optical device includes an optical disc, such as Compact Disc (CD) or Digital Video Disc (DVD). The energy-sensitive dye is disposed over an entire readable surface of the optical device.

System and method for selectively enabling or disabling an optical device

A method and apparatus for controlling access to a storage medium, such as an optically readable medium. Light sensitive or other materials that are adapted to change state and affect reading of a storage medium are used to control access to data that may be stored on optical medium and/or to control use of the medium.

Method and apparatus for controlling access to storage media

Copy-protected optical medium utilizing a composition comprising a transient optical state change security materials constrained to change the optical state light absorption at a wavelength of about 400 nm and an electron transfer agent.

Changing light absorption by disruption of conjugation

A copy-protected optical medium comprising transient optical state change security materials that demonstrating an optical state change when exposed to the wavelengths of from about 770 nm to about 830 nm.

Transient optical state change materials useful in copy-protected compact discs

A computer-readable medium having material at a select position therein and containing instructions for controlling an optical reader to cause the optical reader to re-read the position having the material one or more times to elicit a measurable parameter at such position.

Copy-protected optical media and method of manufacture thereof

Light sensitive materials applied in shipping materials, including security seals and tear tape, for authentication, discrimination and recognition of items.

Growing community of inventors

Guilford, CT, United States of America

Richard H Selinfreund